| Janet Schwan, PA-C | |
|
155 5th St Ne, Barberton, OH 44203-3332 | |
| (330) 615-3000 | |
| Not Available |
| Full Name | Janet Schwan |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Location | 155 5th St Ne, Barberton, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447299615 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 50001242 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Janet Schwan, PA-C 540 Winslow Ave, Akron, OH 44313-5320 Ph: () - | Janet Schwan, PA-C 155 5th St Ne, Barberton, OH 44203-3332 Ph: (330) 615-3000 |
News Archive
In the Huffington Post's "Global Motherhood" blog, Smisha Agarwal, co-founder and India country director of Global Health Bridge, examines the global migration of health workers, highlighting a book titled "Insourced," in which Kate Tulenko, senior director for health systems innovation at IntraHealth International, "argues that the U.S. drains health care workers from poor countries."
A new use of the drug Herceptin appears to offer a much more powerful treatment advantage than expected for patients with HER-2-positive breast cancer, say researchers at The University of Texas M. D. Anderson Cancer Center.
American and British teams led by Drs Kohn (University of California, Los Angeles), Malech (NIH), Williams (Boston Children's) and Trasher (Great Ormond Street Institute of Child Health) published yesterday in Nature Medicine the conclusive results of a gene therapy trial conducted in the United States and Great Britain in 9 patients with X-linked Chronic Septic Granulomatosis (X-CGD), a rare and severe immune dysfunction. Six of them are free of treatment for complications generated by the disease.
Boston Scientific Corporation (NYSE: BSX) today announced the completion of patient enrollment in the workhorse portion of its PLATINUM clinical program. PLATINUM is a global, randomized, pivotal controlled trial designed to support U.S. Food and Drug Administration (FDA) and Japanese Ministry of Health, Labor and Welfare (MHLW) approval of the platinum chromium PROMUS((R)) Element(TM) Everolimus-Eluting Coronary Stent System.
Under the leadership of its national trade association, community pharmacists are stepping up to the plate to take on the issue of medication non-adherence, a health care crisis currently adding to the nation's fiscal woes at a cost of nearly $300 billion each year.
› Verified 9 days ago
Jackson Paul Bonfiglio, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 155 5th St Ne, Barberton, OH 44203 Phone: 330-615-3000 | |
Mr. Timothy J Midura, PA C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 566 East Robinson Ave, Ste 400, Barberton, OH 44203 Phone: 330-753-1015 Fax: 330-753-3103 | |
Lauren Louise Nemunaitis, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 155 5th St Ne, Barberton, OH 44203 Phone: 330-615-3000 | |
Ashley Carmen Heins, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 155 5th St Ne, Barberton, OH 44203 Phone: 330-615-3000 |